Have a good laugh, but the share price is only $0.16 above the $0.22 upper bound of my target set forth in #msg-65473744. You once thought that post was funny too.
p.s. It’s undeniable that Sculptra has been held back to some degree by apprehension about its longevity of action. This information comes directly from injectors who use the product.
News 
Market Data 
Discover 
AI
